BiomedicalPublications

Blood Cancer Journal

Springer Nature·United Kingdom·ISSN 2044-5385

Open accessIn DOAJFee waivers availableMedicine

Blood Cancer Journal is published by Springer Nature as an open access journal (ISSN 2044-5385). The list article processing charge is $5,290. Typical time to publication is 14 wks. Its OpenAlex h-index is 110. Primary field: Medicine. It is listed in the Directory of Open Access Journals. Fee waivers are stated as available. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

$5,290

Open-access article processing charge, list price.

Checked · Journal fee page

Time to publication

14 wks

Broadly typical for the field.

h-index

110

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

7.4

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Blood Cancer Journal is listed at $5,290. The publisher also lists 4,190 EUR, 3,590 GBP. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Blood Cancer Journal, as recorded by OpenAlex for each year. The fee has risen 21% since 2019, from $4,380 to $5,290.

$0$2.6k$5.3k2019: $4,38020192020: $4,58020202021: $4,48020212022: $4,59020222023: $4,79020232024: $4,99020242025: $5,2902025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY, CC BY-NC-ND
Author keeps copyrightNo
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects Blood Cancer Journal publishes most, derived from the topics assigned to its indexed articles.

Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentProtein Degradation and InhibitorsChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchHematopoietic Stem Cell Transplantation

Publication record

Indexed articles2,200
Total citations71,138
i10-index1,379
Most recent indexed article2026
Open access since2011
All ISSNs2044-5385

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.